Back to Authors

Ventola, Pam

A5010933262 | I4210106758

Mayo Clinic

Cogstate Ltd

Citations 3

Zorevunersen Demonstrates Potential as a Disease-modifying Therapy in Patients with Dravet Syndrome Through Durable Seizure Reduction and Improvements in Cognition, Behavior, and Quality of Life Through 36 Months of Treatment in Open-label Extension Studie

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000217057

Zorevunersen in Children and Adolescents with Dravet Syndrome

New England Journal of Medicine | March 4, 2026 | Volume: 394 | Issue: 10 | Pages: 969-982

10.1056/nejmoa2506295 | PMID 41780062

Natural History of Children and Adolescents With Dravet Syndrome

Neurology | November 14, 2025 | Volume: 105 | Issue: 11 | Pages: No page available

10.1212/wnl.0000000000214388 | PMID 41237355